Hepatitis Weekly articles from September 2004

Hepatitis Weekly archives from September 2004

Non-invasive elastometry is a valuable tool for staging liver fibrosis.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Non-invasive elastometry is a valuable tool for staging liver fibrosis. According to a study from Japan, "to assess the efficacy of elastometry in the determination of fibrotic stage in the liver,...

Interferon-gamma signals slow progression in hepatitis C-infected patients.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Interferon-gamma signals slow progression in hepatitis C-infected patients. According to researchers in Japan, "the current study was designed to investigate the immune status in hepatitis C virus...

Rapid steroid withdrawal is appropriate for HCV-positive kidney recipients.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Rapid steroid withdrawal is appropriate for HCV-positive kidney recipients. "The effects of rapid steroid withdrawal (SW) on kidney transplantation (KT) outcome were investigated in 12 HCV+ patients...

Race affects the outcomes of patients awaiting liver transplantations.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Race affects the outcomes of patients awaiting liver transplantations. According to recent research from the United States, "orthotopic liver transplantation (OLT) is the best treatment for...

A new assay distinguishes hepatitis B virus genotype A subtypes.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A new assay distinguishes hepatitis B virus genotype A subtypes. According to recent research published in the Journal of Virology, "the eight genotypes of hepatitis B virus (HBV) have different...

Hemagglutinating virus protein induces immune response with HIV vaccine.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine. "By using the hepatitis B core (HBc) protein gene as a...

Non-genotype 1 hepatitis C virus responds to BILN 2061 therapy.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Non-genotype 1 hepatitis C virus responds to BILN 2061 therapy. "Hepatitis C virus (HCV) displays a high degree of genetic variability. Six genotypes and more than 50 subtypes have been identified...

BPAC recommends COBAS AmpliScreen HBV Test for donated blood.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Roche Diagnostics announced that the Blood Products Advisory Committee (BPAC) of the United States Food and Drug Administration (FDA) voted overwhelmingly that the sensitivity and specificity of Roche's...

Fuzeon maker reports strong Q4 and year-end results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Chronimed, Inc., (CHMD) reported record revenue and earnings for the fourth quarter and year ended July 2, 2004. Total reported company revenue for the 14-week quarter ending July 2, 2004 was a...

Lipid rafts protect hepatitis C virus replication complexes.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Lipid rafts protect hepatitis C virus replication complexes. "The mechanism and machinery of hepatitis C virus (HCV) RNA replication are still poorly characterized. Our previous study has shown...

Disease severity differs in North American and United Kingdom liver recipients.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Disease severity differs in North American and United Kingdom liver recipients. According to recent research published in the journal Liver Transplantation, "the severity of preoperative liver...

Certain dietary supplements pose a threat to liver transplant patients.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Certain dietary supplements pose a threat to liver transplant patients. "The extensive use of alternative medicine products, herbal remedies, and vitamins in large doses has reached an all time high...

Imaging studies enhance the diagnosis and management of infected livers.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Imaging studies enhance the diagnosis and management of infected livers. According to published research from the United States, "recent technologic advances have significantly enhanced the role of...

Lymphadenopathy can't predict how hepatitis C will respond to antivirals.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Lymphadenopathy can't predict how hepatitis C will respond to antivirals. "To identify predictive factors of response to interferon alpha (IFN-alpha) plus ribavirin therapy in patients with chronic...

Ribozyme-based assays detect viral nucleic acids.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Ribozyme-based assays detect viral nucleic acids. "Many reports have suggested that target-activated ribozymes hold potential value as detection reagents. We show that a 'half'-ribozyme ligase is...

Data linking B-cell non-Hodgkin lymphoma to hepatitis C is inconclusive.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Data linking B-cell non-Hodgkin lymphoma to hepatitis C is inconclusive. "A high prevalence of hepatitis C virus (HCV) infection in patients with B-cell non-Hodgkin lymphoma (B-NHL) has been...

Large-volume paracentesis can be performed safely as an outpatient procedure.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Large-volume paracentesis is a treatment used to remove excess fluid in the abdominal cavity resulting from such conditions as cirrhosis of the liver or cardiac failure. It is normally performed as an...

Hepatitis E virus protein regulates extracellular kinases.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Hepatitis E virus protein regulates extracellular kinases. "The hepatitis E virus causes acute viral hepatitis endemic in much of the developing world and is a serious public health problem....

Emerging pharmaceutical company raises series D financing.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Pharmasset announced the completion of a US$40 million series D round of private equity financing led by Burrill & Company. New investor MDS Capital also provided significant participation in the...

ISS-focused company reports $2.9 million second-quarter loss.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Dynavax Technologies Corp. (DVAX), a biopharmaceutical company focused on the discovery, development, and commercialization of products to treat and prevent allergies, infectious diseases, and chronic...

Maker of nucleic acid testing products reports strong financial results in Q2.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Gen-Probe, Inc., (GPRO) reported strong financial results for the second quarter and 6 months ended June 30, 2004. Net income for the second quarter of 2004 was $11.8 million ($0.23 per share),...

Prestara maker reports Q2 loss of $2.9 million.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Genelabs Technologies, Inc., (GNLB) reported contract revenues of $0.7 million and a net loss of $2.9 million, or $0.03 per share, for the second quarter 2004. This compares to revenues of $0.8...

Study says genetic tests could make donated tissue safer.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Just a single donor's tissue might slip through each year infected with HIV or hepatitis, but U.S. donations could be made even safer with genetic testing for the viruses, researchers have found. ...

HIV infections increasing in vulnerable areas of Cambodia.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV infections are increasing in vulnerable areas of Cambodia. According to published research from the United States, "In the past decade, Cambodia has been experiencing the most serious HIV/AIDS...

Incidence of sexually transmitted diseases increasing in Philippines.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The incidence of sexually transmitted diseases is increasing in the Philippines. According to recent research published in the journal AIDS Education and Prevention, "HIV/AIDS has not yet caused a...

HIV/hepatitis prevention urgently needed in drug treatment programs in Hungary.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV and hepatitis prevention is urgently needed in drug treatment programs in Hungary. According to published research from the United States, "We assess HIV and hepatitis testing and counseling in...

Hepatitis B surface S and preS2 antigens expressed in Solanum tuberosum.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Hepatitis B surface S and preS2 antigens have been expressed in tubers of Solanum tuberosum. According to recent research from South Korea, "In an attempt to develop an edible vaccine, we...

Low genetic diversity despite hyperendemicity of HBV genotype E in West Africa.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- There is a low genetic diversity despite a hyperendemicity of hepatitis B viru genotype E in West Africa. According to recent research from Luxembourg, "Sub-Saharan Africa suffers from an...

Reverse transcriptase inhibitors treat woodchuck hepatitis virus.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Reverse transcriptase inhibitors treat woodchuck hepatitis virus. "Our aim was to evaluate the antiviral effect of a combination of two nucleoside reverse transcriptase inhibitors, emtricitabine...

"Self-recovery" from liver infection linked to genes.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C. The viral...

Drug users who are HCV-seronegative may be positive for RNA.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Drug users who are hepatitis C virus-seronegative may be positive for HCV RNA. "Hepatitis C virus (HCV) infection results in chronic liver disease in a substantial proportion of those infected. Most...

Fluorescent marker permits the visualization of HCV replication complexes.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Fluorescent marker permits the visualization of HCV replication complexes. "Hepatitis C virus (HCV) replicates its genome in a membrane-associated replication complex composed of viral proteins,...

FDA approves hepatitis B assay.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The Diagnostics Professional Testing Systems Division of Bayer HealthCare LLC, a member of the Bayer Group (BAY) announced that it has received U.S. Food and Drug Administration (FDA) approval for its...

ELISA for hepatitis E detects antibodies to genotypes 1, 2, 3, and 4.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4. "Two monoclonal antibodies that neutralize hepatitis E virus (HEV) were used to...

Raf-1 activation linked to pathogenesis.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Raf-1 activation appears to be heavily involved in the pathogenesis of hepatocellular carcinoma. "Liver cirrhosis accompanies at least 70% of hepatocellular carcinomas world-wide," hepatologists in...

RhoC expression linked to poor prognosis.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Expression of the RhoC protein in hepatocellular carcinoma is associated with metastasis and poor prognosis. HCC is "one of the most malignant human tumors because of its high incidence of...

Proapoptotic effects of SAMe in HepG2 cells elucidated.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The molecular mechanisms underlying S-adenosylmethionine (SAMe)-induced apoptosis in liver cells have been determined. SAMe "and its metabolite 5'-methylthioadenosine (MTA) are proapoptotic in...

Hepatocellular carcinomas likely to increase in HIV/HBV coinfected patients.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Hepatocellular carcinomas are likely to increase in HIV/HBV coinfected patients. According to recent research from the United States, "Infections with hepatitis B virus (HBV) and human...

Precore mutants associate with fibrosis in hepatitis B patients.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Precore mutants associate with fibrosis in hepatitis B patients. According to research from India, "this study compares the histology of liver biopsies in precore mutant (PCM) and wild-type...

Isolated small intestinal segments support transplanted liver fragments.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Isolated small intestinal segments support transplanted liver fragments. "We determine here the functional integrity of auxiliary livers in containers fashioned from the small intestine. Liver...

Liver transplant recipients face graft rejection with interferon-based therapy.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Liver transplant recipients face graft rejection with interferon-based therapy. According to a study from the United States, "recurrent hepatitis C after liver transplantation remains a significant...

New metabolic syndrome research to begin in South Dakota.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A study into the health risks of metabolic syndrome is about to begin in South Dakota and could involve more than 140 women from the Yankton, Vermillion and northeast Nebraska. Known as the Yankton...

Hepatitis B virus x protein halts apolipoprotein B production in liver cells.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Hepatitis B virus x protein halts apolipoprotein B production in liver cells. "The x protein of hepatitis B virus (HBx) plays a major role on hepatocellular carcinoma (HCC). Apolipoprotein B (apoB)...

MRC more cost-effective than ERCP for diagnosis.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- MRC is more cost-effective than ERCP for the diagnosis of primary sclerosing cholangitis (PSC). "Investigations examining the use of magnetic resonance cholangiography (MRC)" for PSC diagnosis...

Hepatocytes obtained after graft reduction may be used for liver transplant.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Hepatocytes obtained after graft reduction may be used for liver transplantation. "This article describes results obtained when human liver cells obtained from reduced grafts are cultured in a...

Interferon may lead to graft loss in liver transplant recipients.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Interferon may lead to graft loss in liver transplant recipients. According to a study from the United States, "interferon alfa has been increasingly used against recurrent hepatitis C (HCV) disease...

Hepatitis E virus protein ushers liver-specific precursor protein from cells.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Hepatitis E virus protein ushers liver-specific precursor protein from cells. "Hepatitis E virus (HEV), a plus-stranded RNA virus, contains three open reading frames. Of these, ORF1 encodes the...

Glycan loss on hepatitis C virus E1 chimeric glycoprotein impairs infectivity.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Glycan loss on hepatitis C virus E1 chimeric glycoprotein impairs infectivity. "We have previously reported a functional role associated with hepatitis C virus (HCV) E1 glycoprotein using vesicular...

In situ enzyme immunoassay monitors hepatitis A virus growth in cell culture.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- In situ enzyme immunoassay monitors hepatitis A virus growth in cell culture. According to a study from Brazil, "hepatitis A virus (HAV) replicates relatively slowly in cell culture without a...

Peginterferon may cause sustained cryoglobulinemia-related vasculitis.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Peginterferon may cause chronic cryoglobulinemia-related vasculitis. "Peginterferon is now the gold standard of therapy in patients with chronic hepatitis C virus infection. Extrahepatic...

Serum complexes bolster the detection of primary liver cancer.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Serum complexes bolster the detection of primary liver cancer. According to researchers in Italy, "we assessed the presence of alpha-fetoprotein (AFP) complexed with immune globulin M (IgM)...

Key proteins decline in patients with hepatitis C-related liver cancer.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Key proteins decline in patients with hepatitis C-related liver cancer. "Hepatocellular carcinoma (HCC) is a major cause of death in Japan. It has been suggested that hepatitis C virus (HCV) plays...

Patients with high hepatitis C virus loads benefit from long-term therapy.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Patients with high hepatitis C virus loads benefit from long-term therapy. According to a study from Japan, "one hundred seventy-one patients with chronic hepatitis C were included in this study...

Dried blood samples are useful for analyzing hepatitis B virus DNA.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Dried blood samples are useful for analyzing hepatitis B virus DNA. According to new research from Spain, "the purpose of this study was to assess the use of dried blood spot (DBS) samples for...

Indomethacin reduces intracranial pressure in ALF patients.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Indomethacin can be used to reduce intracranial pressure (ICP) during acute liver failure (ALF). Uncontrolled ICP elevation "continues to be one of the most significant causes of early death" in...

Chronic alcohol consumption accelerates T cell-mediated liver injury.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Chronic alcohol consumption accelerates T cell-mediated liver injury. According to recent research from the United States, "alcohol consumption is a major risk factor accelerating the progression...

LymphoStat-B maker provides Q2 clinical milestones, financial losses.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Human Genome Sciences, Inc., (HGSI) announced financial results for the 3-month and 6-month periods ended June 30, 2004. The company's actual net loss for the quarter ended June 30, 2004, in...

Biotechcompany and Novosom enter collaboration and commercial option agreement.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Nucleonics, Inc., and Novosom AG announced that they have entered into a collaboration and commercial option agreement. The two companies will evaluate Novosom's SMARTICLES formulation technology...

Non-nucleoside inhibitors counteract hepatitis C virus polymerase.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Non-nucleoside inhibitors counteract hepatitis C virus polymerase. According to a study from the United States, "chronic hepatitis C virus (HCV) infection is the leading cause of chronic liver...

Novel azapeptide inhibitors quell hepatitis c virus serine protease.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Novel azapeptide inhibitors quell hepatitis c virus serine protease. "Azapeptides are known inhibitors of several serine and cysteine proteases. In seeking different classes of inhibitors for the...

Racial differences characterize the immunology of hepatitis C virus infection.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Racial differences characterize the immunology of hepatitis C virus infection. According to a study from the United States, "African Americans infected with hepatitis C virus (HCV) are less...

Pittsburgh incubator signs Nurel Therapeutics, Inc., as new tenant.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- The Pittsburgh Life Sciences Greenhouse (PLSG) announced that Nurel Therapeutics, Inc., has leased laboratory space in the PLSG Incubator. Nurel Therapeutics is a specialty biotechnology company...

Low adiponectin levels complicate nonalcoholic steatohepatitis.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Low adiponectin levels complicate nonalcoholic steatohepatitis. "Adiponectin has antilipogenic and anti-inflammatory effects, while tumor necrosis factor alpha (TNF-alpha) reduces insulin...

Cell-therapy company updates Q2, reports $1.4 million net loss.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Chromos Molecular Systems, Inc., (CHR), a company focused on the development and commercialization of immune- and gene-based cell therapies and cell line engineering for biopharmaceutical production,...

Hepatitis drug maker reports loss of $0.50 per share.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Anadys Pharmaceuticals, Inc., (ANDS) reported its financial results for the quarter ended June 30, 2004. "We are pleased with the progress we made during the second quarter as we continue to...

High prevalence of HIV/HBV among blood donors in area of Nigeria.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- There is a high prevalence of HIV and hepatitis B virus among blood donors in an area of Nigeria. "The purpose of this study is to determine the rate of human immunodeficiency virus (HIV) and...

Liver disease important cause of morbidity/mortality in HIV infection.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Liver disease is an important cause of morbidity and mortality in HIV infection. According to published research from the United States, "Abnormalities in hepatic function have become one of the...

Study reports on combination therapy for hepatitis C and HIV coninfection.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Patients coinfected with chronic hepatitis C virus (HCV) and HIV treated with PegIntron (peginterferon alfa-2b) and Rebetol (ribavirin) combination therapy achieved significantly higher rates of...

Hepatitis B antigen-pulsed dendritic cells effective in humans.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Hepatitis B surface antigen-pulsed dendritic cells are safe and effective in human volunteers. "Hepatitis B surface antigen (HBsAg)-pulsed murine spleen dendritic cells (DCs) have shown tremendous...

Three cis-acting elements needed for efficient plus-strand HBV DNA synthesis.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Three cis-acting elements are needed for efficient plus-strand hepatitis B DNA synthesis. According to recent research published in the Journal of Virology, "Synthesis of the relaxed-circular (RC)...

Hepatitis C virus co-infection does not alter HIV disease progression.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus co-infection does not alter HIV disease progression. "There is increasing recognition of the potential morbidity and mortality associated with HIV-1 and hepatitis C (HCV)...

Mother-to-infant transmission of HCV is low in Brazil.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Rates of vertical transmission of hepatitis C virus (HCV) are low in Brazil, study data indicate. According to recent research published in the Journal of Tropical Pediatrics, "Sixty-one women...

Select class I alleles associate with hepatitis C virus clearance in women.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Select class I alleles associate with hepatitis C virus clearance in women. "The role of cytotoxic T lymphocyte responses, restricted by human leukocyte antigen (HLA) class I alleles, is recognized...

Virus-specific T cell response doesn't endure after hepatitis C therapy.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Virus-specific T cell response doesn't endure after hepatitis C therapy. "Spontaneous recovery occurs in a minority of patients with acute hepatitis C but is associated with vigorous and...

Leukocyte cell-derived chemotaxin 2 is central to liver cancer formation.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Leukocyte cell-derived chemotaxin 2 is central to liver cancer formation. According to recent research published in the journal Hepatology, "to clarify molecular mechanisms underlying liver...

Pigment epithelium-derived factor gene therapy may treat liver cancer.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Pigment epithelium-derived factor gene therapy may treat liver cancer. According to recent research published in the journal Hepatology, "pigment epithelium-derived factor (PEDF) is one of the most...

Neuropathy is associated with GSD types III, IV, and VI in children.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Liver glycogenoses have been studied as a possible cause of polyneuropathy in a cross-sectional study. According to recent research published in the Journal of Tropical Pediatrics, "We encountered...

Myelomonocytic cells sufficient for therapeutic cell fusion in liver.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Myelomonocytic cells are sufficient for therapeutic cell fusion in the liver. According to a study from the United States, "Liver repopulation with bone marrow-derived hepatocytes (BMHs) can cure...

Organ preservation with HTK can be an alternative to UW solution.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Histidine-tryptophan-ketoglutarate solution for organ preservation in human liver transplantation has been the subject of a prospective multicenter observation study According to a study from...

A web-based resource identifies genotypes of HIV/HCV/HBV sequences.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- A web-based resource identifies the genotypes of HIV/HCV/HBV sequences. According to a study from the United States, "The Genotyping tool at the National Center for Biotechnology Information is a...

Hepatitis B virus X protein increases the invasive potential of liver cancer.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Hepatitis B virus X protein increases the invasive potential of liver cancer. According to published research from South Korea, "hepatitis B virus (HBV) X protein (HBx) has been shown to be...

Combination therapy for chronic hepatitis C may cause pancreatitis.
September 20, 2004... 2004 SEP 20 - (NewsRx.com & NewsRx.net) -- Combination therapy for chronic hepatitis C may cause pancreatitis. According to recent research from the United States, "acute pancreatitis is a rare complication of interferon (IFN) and ribavirin...

HBV-positive kidneys merit prudent use in HBV-infected transplant recipients.
September 20, 2004... 2004 SEP 20 - (NewsRx.com & NewsRx.net) -- HBV-positive kidneys merit prudent use in HBV-infected transplant recipients. "Although renal transplantation has been regarded as the best renal replacement therapy in end-stage renal disease...

CD8-1 is a reporter substrate for cells that harbor hepatitis C replication.
September 20, 2004... 2004 SEP 20 - (NewsRx.com & NewsRx.net) -- CD8-1 is a reporter substrate for cells that harbor hepatitis C replication. "We describe a versatile system for monitoring the activity of the NS3-4A serine protease of the hepatitis C virus (HCV)...